Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Moss

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis and Related Disorders|October 3, 2022
Exploring the impact of the COVID-19 pandemic on social isolation and mental health in people with MSShu Ling, Brandon Moss, Zhini Wang, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|June 4, 2026
Neuropsychological functioning in clinically referred patients with sarcoidosis: a preliminary investigationRachel Galioto, Jeffrey Lambe, Urja Bhatia, et al.
Journal of Patient Experience|October 16, 2020
Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported OutcomesDeborah M Miller, Brandon Moss, Susannah Rose, et al.
Neurodegenerative Disease Management|January 21, 2025
Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practiceMoein Amin, Tucker Harvey, Dan Michael Pineda, et al.
Multiple Sclerosis and Related Disorders|October 12, 2020
Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosisTimothy L Vollmer, Jeffrey A Cohen, Enrique Alvarez, et al.
Neurology. Clinical Practice|January 20, 2025
Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United StatesGiovanna Sophia Manzano, James Eaton, Michael Levy, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|October 3, 2022
Exploring the impact of the COVID-19 pandemic on social isolation and mental health in people with MSShu Ling, Brandon Moss, Zhini Wang, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|June 4, 2026
Neuropsychological functioning in clinically referred patients with sarcoidosis: a preliminary investigationRachel Galioto, Jeffrey Lambe, Urja Bhatia, et al.
Journal of Patient Experience|October 16, 2020
Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported OutcomesDeborah M Miller, Brandon Moss, Susannah Rose, et al.
Neurodegenerative Disease Management|January 21, 2025
Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practiceMoein Amin, Tucker Harvey, Dan Michael Pineda, et al.
Multiple Sclerosis and Related Disorders|October 12, 2020
Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosisTimothy L Vollmer, Jeffrey A Cohen, Enrique Alvarez, et al.
Neurology. Clinical Practice|January 20, 2025
Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United StatesGiovanna Sophia Manzano, James Eaton, Michael Levy, et al.
Pageof 1